Fertility preservation in men with cancer

The Lancet

Volumn 384, Issue 9950, 2014, Pages 1295-1301

  Tournaye, Herman ^a   Dohle, Gert R ^b   Barratt, Christopher L R ^c  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AZOOSPERMIA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL LOSS; CRYOPRESERVATION; FERTILITY PRESERVATION; GERM CELL; HODGKIN DISEASE; HUMAN; INFERTILITY THERAPY; MALE; MALE FERTILITY; NEOPLASM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPERMATOGENESIS; STEM CELL; TESTIS CANCER; INFERTILITY, MALE; NEOPLASMS; PROCEDURES; SPERM RETRIEVAL; SPERMATOGONIUM; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC AGENTS; CRYOPRESERVATION; FERTILITY PRESERVATION; HUMANS; INFERTILITY, MALE; MALE; NEOPLASMS; SPERM RETRIEVAL; SPERMATOGONIA; STEM CELL TRANSPLANTATION;

EID: 84923359390     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60495-5     Document Type: Review

References (69)

1. Paul C, Robaire B. Ageing of the male germ line. Nat Rev Urol 2013; 10: 227-34.
2. Sartorius GA, Nieschlag E. Paternal age and reproduction. Hum Reprod Update 2010; 16: 65-79.
3. Oatley JM, Brinster RL. The germline stem cell niche unit in mammalian testes. Physiol Rev 2012; 92: 577-95.
4. Calogero AE, Garofalo MR, Barone N, et al. Spontaneous regression over time of the germinal epithelium in a Y chromosome-microdeleted patient: Case report. Hum Reprod 2001; 16: 1845-48.
5. Wikström AM, Dunkel L. Testicular function in Klinefelter syndrome. Horm Res 2008; 69: 317-26.
6. Aksglaede L, Juul A. Testicular function and fertility in men with Klinefelter syndrome: a review. Eur J Endocrinol 2013; 168: R67-76.
7. Williams DH 4th, Karpman E, Sander JC, Spiess PE, Pisters LL, Lipshultz LI. Pretreatment semen parameters in men with cancer. J Urol 2009; 181: 736-40.
8. Steliarova-Foucher E, Stiller C, Kaatsch P, et al, and the ACCIS Scientifi c Committee. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study. Lancet 2004; 364: 2097-105.
9. van Casteren NJ, Boellaard WP, Romijn JC, Dohle GR. Gonadal dysfunction in male cancer patients before cytotoxic treatment. Int J Androl 2010; 33: 73-79.
10. Meistrich ML. Eff ects of chemotherapy and radiotherapy on spermatogenesis in humans. Fertil Steril 2013; 100: 1180-86.
11. van der Kaaij MA, van Echten-Arends J, Simons AH, Kluin-Nelemans HC. Fertility preservation after chemotherapy for Hodgkin lymphoma. Hematol Oncol 2010; 28: 168-79.
12. Meistrich ML, Wilson G, Brown BW, da Cunha MF, Lipshultz LI. Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas. Cancer 1992; 70: 2703-12.
13. Loren AW, Mangu PB, Beck LN, et al, and the American Society of Clinical Oncology. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013; 31: 2500-10.
14. Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be off ered? Lancet Oncol 2005; 6: 209-18.
15. Behringer K, Mueller H, Goergen H, et al. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials. J Clin Oncol 2013; 31: 231-39.
16. Romerius P, Ståhl O, Moëll C, et al. High risk of azoospermia in men treated for childhood cancer. Int J Androl 2011; 34: 69-76.
17. Hsiao W, Stahl PJ, Osterberg EC, et al. Successful treatment of postchemotherapy azoospermia with microsurgical testicular sperm extraction: the Weill Cornell experience. J Clin Oncol 2011; 29: 1607-11.
18. van Casteren NJ, van der Linden GH, Hakvoort-Cammel FG, Hählen K, Dohle GR, van den Heuvel-Eibrink MM. Eff ect of childhood cancer treatment on fertility markers in adult male long-term survivors. Pediatr Blood Cancer 2009; 52: 108-12.
19. Chemes HE. Infancy is not a quiescent period of testicular development. Int J Androl 2001; 24: 2-7.
20. Byrne J, Rasmussen SA, Steinhorn SC, et al. Genetic disease in off spring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet 1998; 62: 45-52.
21. Chow EJ, Kamineni A, Daling JR, et al. Reproductive outcomes in male childhood cancer survivors: a linked cancer-birth registry analysis. Arch Pediatr Adolesc Med 2009; 163: 887-94.
22. Ståhl O, Boyd HA, Giwercman A, et al. Risk of birth abnormalities in the off spring of men with a history of cancer: a cohort study using Danish and Swedish national registries. J Natl Cancer Inst 2011; 103: 398-406.
23. Shetty G, Uthamanthil RK, Zhou W, et al. Hormone suppression with GnRH antagonist promotes spermatogenic recovery from transplanted spermatogonial stem cells in irradiated cynomolgus monkeys. Andrology 2013; 1: 886-98.
24. Bunge RG, Sherman JK. Fertilizing capacity of frozen human spermatozoa. Nature 1953; 172: 767-68.
25. Horne G, Atkinson AD, Pease EH, Logue JP, Brison DR, Lieberman BA. Live birth with sperm cryopreserved for 21 years prior to cancer treatment: case report. Hum Reprod 2004; 19: 1448-49.
26. NICE. 2013. http://www.nice.org.uk/cg011 (accessed Sept 9, 2014).
27. Royal College of Physicians. 2007. http://www.rcog.org.uk/womenshealth/clinical-guidance/eff ects-cancer-treatment-reproductivefunction-guidance-management.
28. Gilbert E, Adams A, Mehanna H, Harrison B, Hartshorne GM. Who should be off ered sperm banking for fertility preservation? A survey of UK oncologists and haematologists. Ann Oncol 2011; 22: 1209-14.
29. Quinn GP, Vadaparampil ST, Lee JH, et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol 2009; 27: 5952-57.
30. Sheth KR, Sharma V, Helfand BT, et al. Improved fertility preservation care for male patients with cancer after establishment of formalized oncofertility program. J Urol 2012; 187: 979-86.
31. Hovav Y, Dan-Goor M, Yaff e H, Almagor M. Electroejaculation before chemotherapy in adolescents and young men with cancer. Fertil Steril 2001; 75: 811-13.
32. Schrader M, Müller M, Sofi kitis N, Straub B, Krause H, Miller K. "Onco-tese": testicular sperm extraction in azoospermic cancer patients before chemotherapy-new guidelines? Urology 2003; 61: 421-25.
33. Pacey AA, Merrick H, Arden-Close E, et al. Monitoring fertility (semen analysis) by cancer survivors who banked sperm prior to cancer treatment. Hum Reprod 2012; 27: 3132-39.
34. Barr RD, Clark DA, Booth JD. Dyspermia in men with localized Hodgkin's disease. A potentially reversible, immune-mediated disorder. Med Hypotheses 1993; 40: 165-68.
35. Hotaling JM, Lopushnyan NA, Davenport M, et al. Raw and test-thaw semen parameters after cryopreservation among men with newly diagnosed cancer. Fertil Steril 2013; 99: 464-69.
36. Rives N, Perdrix A, Hennebicq S, et al. The semen quality of 1158 men with testicular cancer at the time of cryopreservation: results of the French National CECOS Network. J Androl 2012; 33: 1394-401.
37. O'Flaherty C, Vaisheva F, Hales BF, Chan P, Robaire B. Characterization of sperm chromatin quality in testicular cancer and Hodgkin's lymphoma patients prior to chemotherapy. Hum Reprod 2008; 23: 1044-52.
38. Smit M, van Casteren NJ, Wildhagen MF, Romijn JC, Dohle GR. Sperm DNA integrity in cancer patients before and after cytotoxic treatment. Hum Reprod 2010; 25: 1877-83.
39. Choy JT, Brannigan RE. The determination of reproductive safety in men during and after cancer treatment. Fertil Steril 2013; 100: 1187-91.
40. Ribas-Maynou J, Fernández-Encinas A, García-Peiró A, et al. Human semen cryopreservation: a sperm DNA fragmentation study with alkaline and neutral Comet assay. Andrology 2014; 2: 83-87.
41. Hourvitz A, Goldschlag DE, Davis OK, Gosden LV, Palermo GD, Rosenwaks Z. Intracytoplasmic sperm injection (ICSI) using cryopreserved sperm from men with malignant neoplasm yields high pregnancy rates. Fertil Steril 2008; 90: 557-63.
42. Agarwal A, Ranganathan P, Kattal N, et al. Fertility after cancer: a prospective review of assisted reproductive outcome with banked semen specimens. Fertil Steril 2004; 81: 342-48.
43. Kelleher S, Wishart SM, Liu PY, et al. Long-term outcomes of elective human sperm cryostorage. Hum Reprod 2001; 16: 2632-39.
44. Bizet P, Saias-Magnan J, Jouve E, et al. Sperm cryopreservation before cancer treatment: a 15-year monocentric experience. Reprod Biomed Online 2012; 24: 321-30.
45. Eiser C, Arden-Close E, Morris K, Pacey AA. The legacy of sperm banking: how fertility monitoring and disposal of sperm are linked with views of cancer treatment. Hum Reprod 2011; 26: 2791-98.
46. Müller J, Skakkebaek NE. Quantifi cation of germ cells and seminiferous tubules by stereological examination of testicles from
47. boys who suff ered from sudden death. Int J Androl 1983; 6: 143-56.
48. Pedersen JL, Nysom K, Jørgensen M, et al. Spermaturia and puberty. Arch Dis Child 1993; 69: 384-87.
49. Nysom K, Pedersen JL, Jørgensen M, et al. Spermaturia in two normal boys without other signs of puberty. Acta Paediatr 1994; 83: 520-21.
50. Berookhim BM, Mulhall JP. Outcomes of operative sperm retrieval strategies for fertility preservation among males scheduled to undergo cancer treatment. Fertil Steril 2014; 101: 805-11.
51. McCook A. A future, on ice. Nat Med 2013; 19: 958-61.
52. Brinster RL, Zimmermann JW. Spermatogenesis following male germ-cell transplantation. Proc Natl Acad Sci USA 1994; 91: 11298-302.
53. Hermann BP, Sukhwani M, Winkler F, et al. Spermatogonial stem cell transplantation into rhesus testes regenerates spermatogenesis producing functional sperm. Cell Stem Cell 2012; 11: 715-26.
54. Baert Y, Goossens E, van Saen D, Ning L, in't Veld P, Tournaye H. Orthotopic grafting of cryopreserved prepubertal testicular tissue: in search of a simple yet eff ective cryopreservation protocol. Fertil Steril 2012; 97: 1152-57, e1-2.
55. Baert Y, Van Saen D, Haentjens P, In't Veld P, Tournaye H, Goossens E. What is the best cryopreservation protocol for human testicular tissue banking? Hum Reprod 2013; 28: 1816-26.
56. Poels J, Van Langendonckt A, Many MC, Wese FX, Wyns C. Vitrifi cation preserves proliferation capacity in human spermatogonia. Hum Reprod 2013; 28: 578-89.
57. Ning L, Meng J, Goossens E, Lahoutte T, Marichal M, Tournaye H. In search of an effi cient injection technique for future clinical application of spermatogonial stem cell transplantation: infusion of contrast dyes in isolated cadaveric human testes. Fertil Steril 2012; 98: 1443-48, e1.
58. Goossens E, Van Saen D, Tournaye H. Spermatogonial stem cell preservation and transplantation: from research to clinic. Hum Reprod 2013; 28: 897-907.
59. Geens M, Goossens E, Tournaye H. Cell selection by selective matrix adhesion is not suffi ciently effi cient for complete malignant cell depletion from contaminated human testicular cell suspensions. Fertil Steril 2011; 95: 787-91.
60. Sadri-Ardekani H, Mizrak SC, van Daalen SK, et al. Propagation of human spermatogonial stem cells in vitro. JAMA 2009; 302: 2127-34.
61. Ruutiainen T, Miller S, Caplan A, Ginsberg JP. Expanding access to testicular tissue cryopreservation: an analysis by analogy. Am J Bioeth 2013; 13: 28-35.
62. van den Berg H, Repping S, van der Veen F. Parental desire and acceptability of spermatogonial stem cell cryopreservation in boys with cancer. Hum Reprod 2007; 22: 594-97.
63. Bahadur G. Ethics of testicular stem cell medicine. Hum Reprod 2004; 19: 2702-10.
64. Stukenborg JB, Schlatt S, Simoni M, et al. New horizons for in vitro spermatogenesis? An update on novel three-dimensional culture systems as tools for meiotic and post-meiotic diff erentiation of testicular germ cells. Mol Hum Reprod 2009; 15: 521-29.
65. Reuter K, Ehmcke J, Stukenborg JB, et al. Reassembly of somatic cells and testicular organogenesis in vitro. Tissue Cell 2014; 46: 86-96.
66. Geijsen N, Horoschak M, Kim K, Gribnau J, Eggan K, Daley GQ. Derivation of embryonic germ cells and male gametes from embryonic stem cells. Nature 2004; 427: 148-54.
67. Hayashi K, Ohta H, Kurimoto K, Aramaki S, Saitou M. Reconstitution of the mouse germ cell specifi cation pathway in culture by pluripotent stem cells. Cell 2011; 146: 519-32.
68. Li Y, Wang X, Feng X, et al. Generation of male germ cells from mouse induced pluripotent stem cells in vitro. Stem Cell Res (Amst) 2014; 12: 517-30.
69. Pacey AA, Eiser C. The importance of fertility preservation in cancer patients. Expert Rev Anticancer Ther 2014; 14: 487-89.